JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M210545200 on November 12, 2002

J. Biol. Chem., Vol. 278, Issue 6, 4205-4215, February 7, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/6/4205    most recent
M210545200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, W.-Q.
Right arrow Articles by Alkon, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, W.-Q.
Right arrow Articles by Alkon, D. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Secretion of Annexin II via Activation of Insulin Receptor and Insulin-like Growth Factor Receptor*

Wei-Qin ZhaoDagger §, Gina H. ChenDagger , Hui Chen||, Alessia PascaleDagger **, Lakshmi RavindranathDagger §, Michael J. Quon||, and Daniel L. AlkonDagger §

From the Dagger  Laboratory of Adaptive Systems, NINDS, National Institutes of Health, Bethesda, Maryland 20892, § Blanchette Rockefeller Neurosciences Institutes, Rockville, Maryland 20850, || Diabetes Unit, LCI, NCCAM, National Institutes of Health, Bethesda, Maryland 20892, and the ** Department of Experimental and Applied Pharmacology, University of Pavia, Pavia, Italy

Annexin II is secreted into the extracellular environment, where, via interactions with specific proteases and extracellular matrix proteins, it participates in plasminogen activation, cell adhesion, and tumor metastasis and invasion. However, mechanisms regulating annexin II transport across the cellular membrane are unknown. In this study, we used coimmunoprecipitation to show that Annexin-II was bound to insulin and insulin-like growth factor-1 (IGF-1) receptors in PC12 cells and NIH-3T3 cells overexpressing insulin (NIH-3T3IR) or IGF-1 receptor (NIH-3T3IGF-1R). Stimulation of insulin and IGF-1 receptors by insulin caused a temporary dissociation of annexin II from these receptors, which was accompanied by an increased amount of extracellular annexin II detected in the media of PC12, NIH-3T3IR, and NIH-3T3IGF-1R cells but not in that of untransfected NIH-3T3 cells. Activation of a different growth factor receptor, the platelet-derived growth factor receptor, did not produce such results. Tyrphostin AG1024, a tyrosine kinase inhibitor of insulin and IGF-1 receptor, was shown to inhibit annexin II secretion along with reduced receptor phosphorylation. Inhibitors of a few downstream signaling enzymes including phosphatidylinositol 3-kinase, pp60c-Src, and protein kinase C had no effect on insulin-induced annexin II secretion, suggesting a possible direct link between receptor activation and annexin II secretion. Immunocytochemistry revealed that insulin also induced transport of the membrane-bound form of annexin II to the outside layer of the cell membrane and appeared to promote cell aggregation. These results suggest that the insulin receptor and its signaling pathways may participate in molecular mechanisms mediating annexin II secretion.


* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Blanchette Rockefeller Neurosciences Inst., 9601 Medical Center Dr., Academic & Research Bldg., 3rd Fl., Rockville, MD 20850. Tel.: 301-294-7179; Fax: 301-294-7007; E-mail: zhaow@brni-jhu.org.


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
S.-H. Oh, W.-Y. Kim, J.-H. Kim, M. N. Younes, A. K. El-Naggar, J. N. Myers, M. Kies, P. Cohen, F. Khuri, W. K. Hong, et al.
Identification of Insulin-Like Growth Factor Binding Protein-3 as a Farnesyl Transferase Inhibitor SCH66336-Induced Negative Regulator of Angiogenesis in Head and Neck Squamous Cell Carcinoma
Clin. Cancer Res., January 15, 2006; 12(2): 653 - 661.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
D. B. N. Lee, N. Jamgotchian, S. G. Allen, F. W. K. Kan, and I. L. Hale
Annexin A2 heterotetramer: role in tight junction assembly
Am J Physiol Renal Physiol, September 1, 2004; 287(3): F481 - F491.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
U. Rescher and V. Gerke
Annexins - unique membrane binding proteins with diverse functions
J. Cell Sci., June 1, 2004; 117(13): 2631 - 2639.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Huang, S. H. Hsia, T. Imamura, I. Usui, and J. M. Olefsky
Annexin II Is a Thiazolidinedione-Responsive Gene Involved in Insulin-Induced Glucose Transporter Isoform 4 Translocation in 3T3-L1 Adipocytes
Endocrinology, April 1, 2004; 145(4): 1579 - 1586.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.